Department of Psychiatry, Duke University Medical Center, Durham, NC, 27705, USA.
Curr Psychiatry Rep. 2010 Oct;12(5):374-81. doi: 10.1007/s11920-010-0142-6.
This article reviews the current treatment literature for attention-deficit/hyperactivity disorder (ADHD) in preschoolers. Parent training studies show consistent behavioral improvements reported by teachers and observers as well as parents, with evidence of clinically significant improvement in ADHD symptoms for up to 2 years. Few other behavioral interventions have been evaluated, although data from a large psychosocial, multimodal intervention are forthcoming. There is evidence to support the benefit of immediate-release stimulant medication for up to 1 year; however, effects do not seem to be as large, and some of the side effects may be greater than for school-age children. With regard to nonstimulants such as atomoxetine, there are literally no controlled outcome data for children with ADHD who are younger than 5 years of age. Overall, a great deal remains to be learned about the safety and efficacy of pharmacotherapy in this age group. Fortunately, results of several large intervention studies will be available soon to better inform clinical practice.
这篇文章回顾了目前针对学龄前儿童注意缺陷多动障碍(ADHD)的治疗文献。家长培训研究显示,教师和观察人员以及家长均报告出一致的行为改善,ADHD 症状有长达 2 年的临床显著改善证据。虽然即将公布一项大型心理社会多模式干预的数据,但很少有其他行为干预措施得到评估。有证据表明,即时释放兴奋剂药物的治疗效果可持续长达 1 年;然而,效果似乎不那么显著,一些副作用可能比学龄儿童更大。至于像托莫西汀这样的非兴奋剂药物,对于年龄在 5 岁以下的 ADHD 儿童,实际上没有对照的结果数据。总的来说,在这个年龄段,药物治疗的安全性和疗效还有很多需要了解的地方。幸运的是,很快就会有几项大型干预研究的结果公布,这将更好地为临床实践提供信息。